Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.

Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors.
复制标题

DOI:
10.1007/s00213-008-1247-z
复制
发表时间:
2008-11
期刊:
影响因子:
3.4
通讯作者:
Geyer, Mark A.
Geyer, Mark A.
中科院分区:
医学3区
文献类型:
--
作者:
Halberstadt, Adam L.;Buell, Mahalah R.;Masten, Virginia L.;Risbrough, Victoria B.;Geyer, Mark A.

文献摘要

参考文献

被引文献

相似文献

被称为ayahuasca的致幻茶是由精神活性植物的组合制成的,这些植物提供活性成分N,N-二甲基色胺(DMT)和5-甲氧基-DMT(5-MeO-DMT),以及单胺氧化酶(MAO)抑制剂(MAOI)骆驼蓬碱和骆驼蓬碱用于口服活性。本研究使用行为模式监测器(BPM),它可以分析自发活动和探索的模式,研究了5-MeO-DMT与MAOIs结合在大鼠中的作用。还使用5-羟色胺(5-HT)1A拮抗剂WAY-100635(1.0 mg/kg)和5-HT 2A拮抗剂MDL 11,939(1.0 mg/kg)进行了相互作用研究,以评估这些受体对MAOI处理动物中5-MeO-DMT行为效应的各自贡献。5-MeO-DMT(0.01、0.1和1.0 mg/kg)降低小鼠的自发活动和行为。在大鼠预处理的行为失活剂量的harlavin(0.1毫克/公斤),1.0毫克/公斤5-MeO-DMT有双相影响的自发活动,最初减少运动,然后增加活动随着时间的推移。选择性单胺氧化酶抑制剂氯吉兰(clorgyline)也具有使5-MeO-DMT转变为双相运动模式的能力,而选择性单胺氧化酶抑制剂(-)-丙炔苯丙胺则无效。用MDL 11,939预处理可阻断由1.0 mg/kg 5-MeO-DMT和0.3 mg/kg氯吉林组合诱导的晚期活动过度。WAY-100635预处理未能减轻早期活动减退或晚期活动过度。哈洛宁改变5-MeO-DMT的行为效应的能力是通过抑制MAOA介导的。此外,5-HT 2A受体负责在MAOA抑制剂存在下由5-MeO-DMT诱导的晚期活动过度。
The hallucinogenic tea known as ayahuasca is made from a combination of psychoactive plants that contribute the active components N,N-dimethyltryptamine (DMT) and 5-methoxy-DMT (5-MeO-DMT), as well as the monoamine oxidase (MAO) inhibitors (MAOIs) harmine and harmaline for oral activity. The present study examined the effects of 5-MeO-DMT in combination with MAOIs in rats using the Behavioral Pattern Monitor (BPM), which enables analyses of patterns of locomotor activity and exploration. Interaction studies using the serotonin (5-HT)1A antagonist WAY-100635 (1.0 mg/kg) and the 5-HT2A antagonist MDL 11,939 (1.0 mg/kg) were also performed to assess the respective contributions of these receptors to the behavioral effects of 5-MeO-DMT in MAOI-treated animals. 5-MeO-DMT (0.01, 0.1, and 1.0 mg/kg) decreased locomotor activity and investigatory behavior. In rats pretreated with a behaviorally inactive dose of harmaline (0.1 mg/kg), 1.0 mg/kg 5-MeO-DMT had biphasic effects on locomotor activity, initially reducing locomotion and then increasing activity as time progressed. The ability of harmaline to shift 5-MeO-DMT to a biphasic locomotor pattern was shared by the selective MAOA inhibitor clorgyline, whereas the selective MAOB inhibitor (−)-deprenyl was ineffective. The late hyperactivity induced by the combination of 1.0 mg/kg 5-MeO-DMT and 0.3 mg/kg clorgyline was blocked by pretreatment with MDL 11,939. Pretreatment with WAY-100635 failed to attenuate either the early hypoactivity or the late hyperactivity. The ability of harmaline to modify the behavioral effects of 5-MeO-DMT is mediated by inhibition of MAOA. Further, 5-HT2A receptors are responsible for the late hyperactivity induced by 5-MeO-DMT in the presence of MAOA inhibitors.
DOI: 10.1037/0735-7044.99.5.881
发表时间: 1985-01-01
影响因子: 1.9
作者:
ADAMS, LM;GEYER, MA
通讯作者: GEYER, MA
DOI: 10.1006/abbi.1996.9771
发表时间: 1997-01-01
影响因子: 3.9
作者:
Kim, H;Sablin, SO;Ramsay, RR
通讯作者: Ramsay, RR
DOI: 10.1081/clt-120030949
发表时间: 2004-01-01
期刊: JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY
影响因子: --
作者:
Brush, DE;Bird, SB;Boyer, EW
通讯作者: Boyer, EW
色胺衍生物与血清素转运蛋白物种变体的相互作用表明跨膜结构域 I 参与底物识别
DOI: 10.1124/mol.59.3.514
发表时间: 2001-03-01
影响因子: 3.6
作者:
Adkins, EM;Barker, EL;Blakely, RD
通讯作者: Blakely, RD
DOI: 10.1016/s1056-8719(02)00159-4
发表时间: 2001-07-01
影响因子: 1.9
作者:
Eckler, JR;Greizerstein, H;Winter, JC
通讯作者: Winter, JC